AliveCor

AliveCor is a pioneer and leader in the consumer-facing personal electrocardiogram (EKG) market, founded in 2011. The company's core product line, Kardia, includes several FDA-cleared, portable devices that record medical-grade EKGs which are analyzed via a smartphone app for arrhythmias like atrial fibrillation (AFib). AliveCor has built a significant installed base, recording over 300 million EKGs globally, and has expanded its business model to include a recurring revenue subscription service (KardiaCare) offering advanced analytics and telehealth support. The company operates as a private entity, competing directly with large consumer electronics and wearable companies while navigating a complex regulatory and reimbursement landscape.

Integrated hardware-software platform for personal electrocardiogram (EKG) recording and AI-based arrhythmia analysis. Includes portable EKG devices (1-lead and 6-lead) that pair with a smartphone app for immediate, FDA-cleared detection of multiple arrhythmias, data storage, and telehealth integration.

AliveCor competes in two overlapping arenas: the medical-grade personal ECG market (e.g., competitors like iRhythm for ambulatory monitoring) and the consumer health wearable market (e.g., Apple Watch, Fitbit, Samsung Galaxy Watch). Its key differentiation is FDA clearance for specific arrhythmia detection and a focus on clinical utility, but it faces immense pressure from competitors with greater brand recognition, distribution, and ecosystem integration.